Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) |
EINECS | 260-856-8 |
CAS No. | 57625-97-5 | Density | g/cm3 |
PSA | 123.38000 | LogP | 5.45320 |
Solubility | N/A | Melting Point |
N/A |
Formula | C36H36N4•C4H6O4 | Boiling Point | 449.2 °C at 760 mmHg |
Molecular Weight | 380.444 | Flash Point | 225.5 °C |
Transport Information | N/A | Appearance | N/A |
Safety | A poison by intravenous route. Human systemic effects: ocular ptosis, muscle weakness. When heated to decomposition it emits toxic vapors of NOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
CIBENZOLINE SUCCINATE;cifenlinesuccinate |
Article Data | 2 |
Molecular Structure of 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) (CAS NO.57625-97-5):
IUPAC Name: butanedioic acid; 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
Empirical Formula: C40H42N4O4
Molecular Weight: 642.7859
Flash Point: 225.5 °C
Enthalpy of Vaporization: 68.06 kJ/mol
Boiling Point: 449.2 °C at 760 mmHg
Vapour Pressure: 7.75E-08 mmHg at 25°C
Synonyms of 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) (CAS NO.57625-97-5):
2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole succinate (2:1) ; Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:2) ; Succinic acid, compound with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:2)
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 41500ug/kg (41.5mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
women | TDLo | oral | 300mg/kg/22W- (300mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: MUSCLE WEAKNESS | Internal Medicine. Vol. 35, Pg. 512, 1996. |
2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) (CAS NO.57625-97-5) was reported by KSRNAM Kiso to Rinsho in Clinical Report.
A poison by intravenous route. Human systemic effects: ocular ptosis, muscle weakness. When heated to decomposition it emits toxic vapors of NOx.